Citations

Mayo Clinic

Clear

23 citation(s) found for "Ma, Sisi".

Prediction of post-operative residual disease in advanced-stage ovarian cancer (AOC) using whole transcriptome expression: An exploratory analysis of the AGO-OVAR 11 (ICON7) trial.
Kommoss, Stefan , Winterhoff, Boris , Aliferis, Constantin , Burges, Alexander , Canzler, Ulrich , Wang, Jinhua , Belau, Antje , Hanker, Lars , Ma, Sisi , Hilpert, Felix , Tourani, Roshan , Kimmig, Rainer , Kurzeder, Christian , Schmalfeldt, Barbara , Dowdy, Sean C. , Pfisterer, Jacobus , Heitz, Florian , Wang, Chen , Ma, Sisi , Sehouli, Jalid , Bois, Andreas du

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 5550-5550

10.1200/jco.2018.36.15_suppl.5550 Get It

Significant overall survival improvement in proliferative subtype ovarian cancer patients receiving bevacizumab.
Kommoss, Stefan , Winterhoff, Boris , Wang, Chen , Aliferis, Constantin , Kimmig, Rainer , Wang, Jinhua , Ma, Sisi , Gregorio, Nikolaus de , Mahner, Sven� , Tourani, Roshan , Park‐Simon, Tjoung‐Won , Baumann, Klaus , Taran, Florin‐Andrei , Kommoss, Friedrich, Schroeder, W., Dowdy, Sean C. , Pfisterer, Jacobus , Heitz, Florian , Sehouli, Jalid , Ma, Sisi , Bois, Andreas du

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 5520-5520

10.1200/jco.2018.36.15_suppl.5520 Get It

TSPYL Family Regulates CYP17A1 and CYP3A4 Expression: Potential Mechanism Contributing to Abiraterone Response in Metastatic Castration‐Resistant Prostate Cancer
Liu, Duan , Wang, Liguo , Vedell, Peter T. , Niu, Nifang, Yu, Jia , Weinshilboum, Richard M. , Wang, Liewei , Kohli, Manish , Hillman, David W. , Wang, Liguo , Qin, Sisi , Weinshilboum, Richard M. , Liu, Duan

Clinical Pharmacology & Therapeutics | October 13, 2017 | Volume: 104 | Issue: 1 | Pages: 201-210

10.1002/cpt.907 | PMID 29027195 Get It

The testis‐specific Y‐encoded‐like protein (TSPYL) gene family includes TSPYL1 to TSPYL6. We previously reported that TSPYL5 regulates cytochrome P450 (CYP) 19A1 expression. Here we show that TSPYLs, especially TSPYL 1, 2, and 4, can regulate the expression of many CYP genes, including CYP17A1, a key enzyme in androgen biosynthesis, and CYP3A4, an enzyme that catalyzes the metabolism of abiraterone, a CYP17 inhibitor. Furthermore, a common TSPYL1 single nucleotide polymorphism (SNP), rs3828743 (G/A) (Pro62Ser), abolishes TSPYL1's ability to suppress CYP3A4 expression, resulting in reduced abiraterone concentrations and increased cell proliferation. Data from a prospective clinical trial of 87 metastatic castration‐resistant prostate cancer patients treated with abiraterone acetate/prednisone showed that the variant SNP genotype (A) was significantly associated with worse response and progression‐free survival. In summary, TSPYL genes are novel CYP gene transcription regulators, and genetic alteration within these genes significantly influences response to drug therapy through transcriptional regulation of CYP450 genes.